Testing new blood or breathing markers for emphysema detection
Part of Lungs & breathing clinical trials.
This study looks for new measurable signs (“markers”) that can help detect emphysema earlier and more accurately. You may be asked to have breathing measurements and complete tasks if you have COPD and have had a recent chest CT scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You currently have breathing symptoms such as shortness of breath, cough, or mucus
- Your breathing test shows airflow blockage that does not fully improve with an inhaler
- You have COPD risk factors or causes, and your CT scan within the last 12 months shows emphysema changes
- You can read and write Dutch
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether measurements of your breathing muscle (the diaphragm) can act as a useful “biomarker” to track lung disease. You might be asked to do breathing tests and follow study instructions, and your results may help researchers better monitor COPD, asthma, fibrosis, or pulmonary hypertension.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
This study tests a new way to spot early signs of blocked airways in people with COPD during a routine breathing test. The goal is to catch problems sooner and help guide treatment.
This study looks at data from people who had a lung health check to see if a new breathing test can help find COPD or early signs of it. It might make it easier to diagnose COPD sooner.
This study looks at a lung protein called MMP12 in sputum (mucus) to better understand COPD. It may help researchers learn which COPD changes are linked to disease severity and lung damage.
This study tests a portable device that measures how well your lungs work by sending gentle sound waves or pulses through them. It aims to see if this new device can accurately detect and differentiate various chronic lung conditions, potentially offering a simpler and more accessible way to monitor respiratory health.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.